The cost, quality of life impact, and cost-utility of bariatric surgery in a managed care population.
Our purpose was to assess the cost, quality of life impact, and the cost-utility of bariatric surgery in a managed care population. We studied 221 patients who underwent bariatric surgery between 2001 and 2005. We analyzed medical claims data for all patients and survey data for 122 survey respondents (55% response rate). Patients were generally middle-aged, female, and white. Sixty-four percent underwent open and 33% underwent laparoscopic Roux-en-Y procedures. One year after surgery, mean body mass index fell from 51 to 31 kg/m(2) in women and from 59 to 35 kg/m(2) in men with substantial improvements in comorbidities. Postsurgical mortality and morbidity were low. Total per member per month costs increased in the 6 months before bariatric surgery, were lower in the 12 months after bariatric surgery, but increased somewhat over the next 12 months. When presurgical quality of life was assessed prospectively, average health utility scores improved by 0.14 one year after surgery. In analyses that took a lifetime time horizon, projected future costs based on age and obesity and discounted costs and health utilities at 3% per year, the cost-utility ratio for bariatric surgery versus no surgery was approximately $1,400 per quality-adjusted life-year gained. In sensitivity analyses, bariatric surgery was more cost-effective in women, non-whites, more obese patients, and when performed laparoscopically. Although not cost-saving, bariatric surgery represents a very good value for money. Its long-term cost effectiveness appears to depend on the natural history and cost of late postsurgical complications and the natural history and cost of untreated morbid obesity.
McEwen
Laura N
LN
Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Health System, 1500 E. Medical Center Dr. 3920 Taubman Center, Ann Arbor, MI 48109-5354, USA.
Coelho
Renuka B
RB
Baumann
Lauren M
LM
Bilik
Dori
D
Nota-Kirby
Betsy
B
Herman
William H
WH
D000328:Adult; D000713:Anastomosis, Roux-en-Y / Q000191:economics*; D050110:Bariatric Surgery / Q000191:economics*; D015992:Body Mass Index; D003362:Cost-Benefit Analysis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D010535:Laparoscopy / Q000191:economics*; D008297:Male; D008329:Managed Care Programs / Q000191:economics*; D008875:Middle Aged; D009767:Obesity, Morbid / Q000601:surgery*; D017063:Outcome Assessment, Health Care; D011788:Quality of Life; D019057:Quality-Adjusted Life Years; D016896:Treatment Outcome; D014481:United States
JAMA. 2005 Apr 20;293(15):1861-7
15840860
Diabetes Care. 2009 Apr;32(4):567-74
19171720
Obes Surg. 2005 May;15(5):641-7
15946454
Int J Obes Relat Metab Disord. 2003 Oct;27(10):1167-77
14513064
Am J Manag Care. 2009 Sep;15(9):607-15
19747025
JAMA. 2006 Apr 5;295(13):1549-55
16595758
Surg Obes Relat Dis. 2008 Jan-Feb;4(1):26-32
18069075
Obes Surg. 2006 Jan;16(1):75-84
16417762
Am J Manag Care. 2008 Sep;14(9):561-2
18778170
Ann Intern Med. 2005 Apr 5;142(7):547-59
15809466
Obes Surg. 2006 Nov;16(11):1488-503
17132416
Int J Obes (Lond). 2007 Jan;31(1):189-96
16682976
Mayo Clin Proc. 2006 Oct;81(10 Suppl):S5-10
17036573
Ann Intern Med. 1993 Oct 1;119(7 Pt 2):764-70
8363212
Obes Surg. 2004 Sep;14(8):1031-5
15479590
Am J Med. 2002 Oct 15;113(6):491-8
12427499
Obes Surg. 2004 Jun-Jul;14(6):725-30
15318973
PLoS Med. 2008 Feb;5(2):e29
18254654
Am J Manag Care. 2008 Sep;14(9):589-96
18778174
N Engl J Med. 2007 Aug 23;357(8):741-52
17715408
Med Care. 2005 Mar;43(3):203-20
15725977
Diabetes Care. 2009 Apr;32(4):580-4
19171726
Mod Healthc. 2006 Oct 2;36(39):6-7, 16, 1
17036866